Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Fesoterodine

    Client Email Product

    Fesoterodine

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    25
    US DMFs Filed

    US DMFs Filed

    15
    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    6
    Other Suppliers

    Other Suppliers

    14
    API REF. PRICE (USD / KG)
    6,507

    API Market Place

    3
    INTERMEDIATES
    4
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    30
    Europe

    Europe

    15
    Canada

    Canada

    4
    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Uploaded Dossiers

    Uploaded Dossiers

    14
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    1,186.00

    Annual Reports

    270.00

    FDF Market Place

    0

    EXCIPIENTS
    181
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    12

    USFDA Exclusivities

    4
    DIGITAL CONTENT

    Blog #PharmaFlow

    1

    News

    20
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    0

    SERVICES

    0

    left grey arrow
    right gray arrow
    • TABLET, EXTENDED RELEASE;ORAL - 4MG
    • TABLET, EXTENDED RELEASE;ORAL - 8MG
    Full View ScreenFull Screen View
    Hetero`s Generic Fesoterodine Fumarate Receives Approval in the U.S.
    Hetero`s Generic Fesoterodine Fumarate Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204792

    FDA
    09 Jan 2024
    Share Share
    Lupin's Generic Fesoterodine Fumarate Receives Approval in the U.S.
    Lupin's Generic Fesoterodine Fumarate Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204983

    FDA
    05 Jan 2023
    Share Share
    Accord healthcare's Generic Fesoterodine Fumarate Receives Approval in U.S.
    Accord healthcare's Generic Fesoterodine Fumarate Receives Approval in U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205012

    FDA
    04 Jan 2023
    Share Share
    ANI Pharm's Generic Fesoterodine Fumarate Receives Approval in U.S.
    ANI Pharm's Generic Fesoterodine Fumarate Receives Approval in U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204504

    FDA
    04 Jan 2023
    Share Share
    Actavis Lab's Generic Fesoterodine Fumarate Receives Approval in U.S.
    Actavis Lab's Generic Fesoterodine Fumarate Receives Approval in U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204868

    FDA
    04 Jan 2023
    Share Share
    Amneal Pharm's Generic Fesoterodine Fumarate Receives Approval in U.S.
    Amneal Pharm's Generic Fesoterodine Fumarate Receives Approval in U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205002

    FDA
    04 Jan 2023
    Share Share
    Amerigen's Generic Fesoterodine Fumarate Receives Approval in the U.S.
    Amerigen's Generic Fesoterodine Fumarate Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204504

    FDA
    12 Oct 2022
    Share Share
    Dr. Reddy's Laboratories Launches Fesoterodine Fumarate ER Tablets in U.S.
    Dr. Reddy's Laboratories Launches Fesoterodine Fumarate ER Tablets in U.S.

    https://www.nasdaq.com/press-release/dr.-reddys-laboratories-announces-the-launch-of-fesoterodine-fumarate-extended

    NASDAQ
    09 Jul 2022
    Share Share
    Alembic Pharma gets tentative USFDA nod for fesoterodine fumarate ER tablets
    Alembic Pharma gets tentative USFDA nod for fesoterodine fumarate ER tablets

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharma-gets-tentative-usfda-nod-for-fesoterodine-fumarate-extended-release-tablets/articleshow/89291718.cms

    ECONOMIC TIMES
    02 Feb 2022
    Share Share
    Alembic Pharms' Generic Fesoterodine Fumarate Receives Approval in the U.S.
    Alembic Pharms' Generic Fesoterodine Fumarate Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204973

    FDA
    31 Jan 2022
    Share Share
    Amneal Pharm's Generic Fesoterodine Fumarate Receives Approval in the U.S.
    Amneal Pharm's Generic Fesoterodine Fumarate Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205002

    FDA
    21 Jan 2022
    Share Share
    Actavis Lab's Generic Fesoterodine Fumarate Receives Approval in the U.S.
    Actavis Lab's Generic Fesoterodine Fumarate Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204868

    FDA
    11 Jan 2022
    Share Share
    Mylan Pharms`s fesoterodine fumarate Receives Tentative Approval in US
    Mylan Pharms`s fesoterodine fumarate Receives Tentative Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206701

    FDA
    14 Aug 2020
    Share Share
    Torrent Pharms' Generic Fesoterodine Fumarate Receives Tentative Approval in US
    Torrent Pharms' Generic Fesoterodine Fumarate Receives Tentative Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209783

    FDA
    20 Oct 2018
    Share Share
    Four pharmas named for breaching ABPI Code of Practice
    Four pharmas named for breaching ABPI Code of Practice

    http://www.pharmatimes.com/news/four_pharmas_named_for_breaching_abpi_code_of_practice_1244873

    Selina McKee PHARMA TIMES
    20 Jul 2018
    Share Share
    Zydus Pharm’s Generic Fesoterodine Fumarate Receives Approval in US
    Zydus Pharm’s Generic Fesoterodine Fumarate Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204946

    FDA
    07 Oct 2017
    Share Share
    USFDA approves aurobindo’s ANDA for pfizer’s toviaz
    USFDA approves aurobindo’s ANDA for pfizer’s toviaz

    http://twofourinsight.com/usfda-approves-aurobindo-anda-pfizer-toviaz/

    TWO FOUR INSIGHT
    03 May 2016
    Share Share
    Amerigen Gets Tentative FDA Approval for Generic Toviaz
    Amerigen Gets Tentative FDA Approval for Generic Toviaz

    http://www.fdanews.com/articles/171128-amerigen-gets-tentative-fda-approval-for-generic-toviaz

    Jonathon Shacat FDA NEWS
    11 May 2015
    Share Share
    Sandoz' Generic Fesoterodine Fumarate Tentatively Approved in US For Overactive Bladder
    Sandoz' Generic Fesoterodine Fumarate Tentatively Approved in US For Overactive Bladder

    https://www.pharmacompass.com/pdf/news/n51.pdf

    Press Release FDA
    05 May 2015
    Share Share
    Amerigen's Generic Toviaz (Fesoterodine Fumarate 4mg and 8mg) Tentatively Approved in US For Overactive Bladder
    Amerigen's Generic Toviaz (Fesoterodine Fumarate 4mg and 8mg) Tentatively Approved in US For Overactive Bladder

    http://www.amerigenpharma.com/?p=1929

    Press Release AMRIGEN
    29 Apr 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search